Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-04 Sale |
2024-03-05 4:24 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
2,447 | $7.77 | $19,013 | 101,479 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-30 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,849 | $5 | $9,245 | 103,926 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:29 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
7,028 | $4.37 | $30,712 | 105,775 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-03 4:03 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,182 | $3.66 | $18,966 | 112,803 (Direct) |
View |
| 2023-12-18 Sale |
2023-12-19 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,585 | $3.5 | $5,548 | 117,985 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 4:02 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
4,718 | $2.8 | $13,210 | 119,570 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-06 5:18 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,182 | $4.83 | $25,029 | 124,288 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:06 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
7,331 | $5.24 | $38,414 | 129,470 (Direct) |
View |
| 2022-08-18 Sale |
2022-08-19 6:58 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
5,135 | $29.81 | $153,051 | 136,801 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:06 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
1,770 | $48.45 | $85,757 | 108,634 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-21 4:08 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
15,977 | $60 | $958,620 | 238,642 (Direct) |
View |
| 2021-09-28 Sale |
2021-09-30 4:14 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
19,460 | $62.53 | $1,216,834 | 195,079 (Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 4:01 pm |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
3,474 | $88.26 | $306,602 | 54,539 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 4:34 pm |
N/A 2035-02-28 |
Intellia Therapeutics Inc. | NTLA | Dulac Edward J III EVP, Chief Financial Officer |
114,629 | $0 | 180,953 (Direct) |
View |
| 2024-07-22 Option Award |
2024-07-24 4:17 pm |
N/A 2034-07-21 |
Intellia Therapeutics Inc. | NTLA | Dulac Edward J III EVP, Chief Financial Officer |
162,543 | $0 | 162,543 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:09 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:15 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:35 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
86,360 | $0 | 194,994 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $35.52 | 238,642 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-21 4:08 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
14,437 | $0 | 238,642 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:41 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
59,540 | $0 | 111,944 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-30 4:14 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
17,325 | $35.52 | 195,079 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-30 4:14 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
17,325 | $0 | 195,079 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:18 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
24,864 | $0 | 64,864 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-19 4:12 pm |
N/A 2030-08-17 |
FATE THERAPEUTICS INC | FATE | Dulac Edward J III Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |